NCT07043608 2025-07-02ZAMBONIUniversity of California, San FranciscoPhase 2 Not yet recruiting20 enrolled
NCT00896454 2018-10-17Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumAmgenPhase 2 Completed33 enrolled 22 charts
NCT00091832 2014-01-28Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast CancerAmgenPhase 2 Completed255 enrolled 34 charts